MaxCyte, Inc. (MXCT)
NASDAQ · Healthcare
MaxCyte, Inc. Balance Sheet 2019–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total Assets | 202.5M | 239.5M | 268.3M | 286.7M | 284.1M | 51.8M |
| Cash & Equivalents | 20.1M | 27.9M | 46.5M | 11.1M | 47.8M | 18.8M |
| Liabilities | ||||||
| Total Liabilities | 31.0M | 33.2M | 36.1M | 32.7M | 21.2M | 18.6M |
| Long-Term Debt | — | — | — | — | — | — |
| Equity | ||||||
| Shareholders' Equity | 171.5M | 206.3M | 232.2M | 254.0M | 262.9M | 33.2M |
MaxCyte, Inc. Balance Sheet — FAQ
MaxCyte, Inc. (MXCT) balance sheet over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MXCT's balance sheet history?
The chart and table above show MaxCyte, Inc.'s balance sheet by year and by quarter, including the growth rate.